Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy in Children—A Literature Review
Journal of Clinical Medicine · 29.01.2024 · 13 (3) · 780
DOI: 10.3390/jcm13030780 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.01.2024. Verfasst von Mitsumasa Fukuda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropediatrics, Tokyo Metropolitan Neurological Hospital, Fuchu 183-0042, Japan. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant-in-Aid for Scientific Research (C), Grant-in-Aid for Early-Career Scientists.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Vagus nerve stimulation (VNS) is a palliative treatment for drug-resistant epilepsy (DRE) that has been in use for over two decades. VNS suppresses epileptic seizures, prevents emotional disorders, and improves cognitive function and sleep quality, a parallel effect associated with the control of epileptic seizures. The seizure suppression rate with VNS increases monthly to annually, and the incidence of side effects reduces over time. This method is effective in treating DRE in children as well as adults, such as epilepsy associated with tuberous sclerosis, Dravet syndrome, and Lennox–Gastaut syndrome. In children, it has been reported that seizures decreased by >70% approximately 8 years after initiating VNS, and the 50% responder rate was reported to be approximately 70%. VNS regulates stimulation and has multiple useful systems, including self-seizure suppression using magnets, additional stimulation using an automatic seizure detection system, different stimulation settings for day and night, and an automatic stimulation adjustment system that reduces hospital visits. VNS suppresses seizures and has beneficial behavioral effects in children with DRE. This review describes the VNS system, the mechanism of the therapeutic effect, the specific stimulation adjustment method, antiepileptic effects, and other clinical effects in patients with childhood DRE.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neuropediatrics, Tokyo Metropolitan Neurological Hospital, Fuchu 183-0042, Japan.
- Department of Neurosurgery, Tokyo Metropolitan Neurological Hospital, Fuchu 183-0042, Japan.
ORCID-Profile: Mitsumasa Fukuda, Takeshi Matsuo, Ai Hoshino
Förderung
- Grant-in-Aid for Scientific Research (C)
- Grant-in-Aid for Early-Career Scientists
Zitieren
APA
Fukuda, M., Matsuo, T., Fujimoto, S., Kashii, H., Hoshino, A., Ishiyama, A., & Kumada, S. (2024). Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy in Children—A Literature Review. Journal of Clinical Medicine, 13(3), 780. https://doi.org/10.3390/jcm13030780
Vancouver
Fukuda M, Matsuo T, Fujimoto S, Kashii H, Hoshino A, Ishiyama A, et al. Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy in Children—A Literature Review. Journal of Clinical Medicine. 2024;13(3):780. doi:10.3390/jcm13030780
BibTeX
@article{Fukuda2024,
author = {Fukuda, Mitsumasa and Matsuo, Takeshi and Fujimoto, So and Kashii, Hirofumi and Hoshino, Ai and Ishiyama, Akihiko and Kumada, Satoko},
title = {Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy in Children—A Literature Review},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {3},
pages = {780},
doi = {10.3390/jcm13030780}
}
EUVIMED